Strategies for Myocardial Repair

GOU YOUNG KOH, MARK H. SOONPAA, MICHAEL G. KLUG, LOREN J. FIELD

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The therapeutic recourse for end-stage heart disease is currently limited to cardiac transplantation. The ability to augment cardimyocyte number in an end-stage heart might facilitate myocardial function. Augmentation of cardiomyocyte number may be achievable by the targeted expression of cell cycle regulatory genes to the myocardium. Alternatively, intracardiac grafting of exogenous cardiomyocytes might also provide a viable approach to augment cardiomyocyte number. Potential strategies for heart muscle regeneration via gene therapy and cellular transplantation are discussed.

Original languageEnglish (US)
Pages (from-to)387-393
Number of pages7
JournalJournal of interventional cardiology
Volume8
Issue number4
DOIs
StatePublished - Aug 1995

Fingerprint

Cardiac Myocytes
Myocardium
cdc Genes
Heart Transplantation
Regulator Genes
Genetic Therapy
Regeneration
Heart Diseases
Transplantation
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Strategies for Myocardial Repair. / KOH, GOU YOUNG; SOONPAA, MARK H.; KLUG, MICHAEL G.; FIELD, LOREN J.

In: Journal of interventional cardiology, Vol. 8, No. 4, 08.1995, p. 387-393.

Research output: Contribution to journalArticle

KOH, GOU YOUNG ; SOONPAA, MARK H. ; KLUG, MICHAEL G. ; FIELD, LOREN J. / Strategies for Myocardial Repair. In: Journal of interventional cardiology. 1995 ; Vol. 8, No. 4. pp. 387-393.
@article{77ad650ce8ec4c8ea883fd7114f49886,
title = "Strategies for Myocardial Repair",
abstract = "The therapeutic recourse for end-stage heart disease is currently limited to cardiac transplantation. The ability to augment cardimyocyte number in an end-stage heart might facilitate myocardial function. Augmentation of cardiomyocyte number may be achievable by the targeted expression of cell cycle regulatory genes to the myocardium. Alternatively, intracardiac grafting of exogenous cardiomyocytes might also provide a viable approach to augment cardiomyocyte number. Potential strategies for heart muscle regeneration via gene therapy and cellular transplantation are discussed.",
author = "KOH, {GOU YOUNG} and SOONPAA, {MARK H.} and KLUG, {MICHAEL G.} and FIELD, {LOREN J.}",
year = "1995",
month = "8",
doi = "10.1111/j.1540-8183.1995.tb00564.x",
language = "English (US)",
volume = "8",
pages = "387--393",
journal = "Journal of Interventional Cardiology",
issn = "0896-4327",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Strategies for Myocardial Repair

AU - KOH, GOU YOUNG

AU - SOONPAA, MARK H.

AU - KLUG, MICHAEL G.

AU - FIELD, LOREN J.

PY - 1995/8

Y1 - 1995/8

N2 - The therapeutic recourse for end-stage heart disease is currently limited to cardiac transplantation. The ability to augment cardimyocyte number in an end-stage heart might facilitate myocardial function. Augmentation of cardiomyocyte number may be achievable by the targeted expression of cell cycle regulatory genes to the myocardium. Alternatively, intracardiac grafting of exogenous cardiomyocytes might also provide a viable approach to augment cardiomyocyte number. Potential strategies for heart muscle regeneration via gene therapy and cellular transplantation are discussed.

AB - The therapeutic recourse for end-stage heart disease is currently limited to cardiac transplantation. The ability to augment cardimyocyte number in an end-stage heart might facilitate myocardial function. Augmentation of cardiomyocyte number may be achievable by the targeted expression of cell cycle regulatory genes to the myocardium. Alternatively, intracardiac grafting of exogenous cardiomyocytes might also provide a viable approach to augment cardiomyocyte number. Potential strategies for heart muscle regeneration via gene therapy and cellular transplantation are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0029154220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029154220&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8183.1995.tb00564.x

DO - 10.1111/j.1540-8183.1995.tb00564.x

M3 - Article

C2 - 10155253

AN - SCOPUS:0029154220

VL - 8

SP - 387

EP - 393

JO - Journal of Interventional Cardiology

JF - Journal of Interventional Cardiology

SN - 0896-4327

IS - 4

ER -